Amphetamine Related Published Studies
Well-designed clinical trials related to Amphetamine
Interactions between bupropion and 3,4-methylenedioxymethamphetamine in healthy
subjects. [2015]
Effect of extended-release dexmethylphenidate and mixed amphetamine salts on
sleep: a double-blind, randomized, crossover study in youth with
attention-deficit hyperactivity disorder. [2014]
State dependent effect of transcranial direct current stimulation (tDCS) on
methamphetamine craving. [2014]
A randomized, controlled pilot study of MDMA (±
3,4-Methylenedioxymethamphetamine)-assisted psychotherapy for treatment of
resistant, chronic Post-Traumatic Stress Disorder (PTSD). [2013]
Cigarette smoking as a target for potentiating outcomes for methamphetamine abuse
treatment. [2013]
A retrospective analysis of two randomized trials of bupropion for
methamphetamine dependence: suggested guidelines for treatment
discontinuation/augmentation. [2012]
Dexamphetamine improves upper extremity outcome during rehabilitation after stroke: a pilot randomized controlled trial. [2011.10]
Medication adherence and symptom reduction in adults treated with mixed amphetamine salts in a randomized crossover study. [2011.09]
The influence of depression on treatment for methamphetamine use. [2011.08.01]
Quality of life among treatment seeking methamphetamine-dependent individuals. [2011.07]
Functional magnetic resonance imaging investigation of the amphetamine sensitization model of schizophrenia in healthy male volunteers. [2011.06]
Comparison of the behavioral and cardiovascular effects of intranasal and oral d-amphetamine in healthy human subjects. [2011.06]
Bulimia nervosa among methamphetamine dependent adults: association with outcomes three years after treatment. [2011.05]
Effect of modafinil on learning and task-related brain activity in methamphetamine-dependent and healthy individuals. [2011.04]
The safety and efficacy of {+/-}3,4-methylenedioxymethamphetamine-assisted psychotherapy in subjects with chronic, treatment-resistant posttraumatic stress disorder: the first randomized controlled pilot study. [2011.04]
Zinc for attention-deficit/hyperactivity disorder: placebo-controlled double-blind pilot trial alone and combined with amphetamine. [2011.02]
A randomized, placebo-controlled trial of sustained-release dextroamphetamine for treatment of methamphetamine addiction. [2011.02]
Acute effects of MDMA (3,4-methylenedioxymethamphetamine) on EEG oscillations: alone and in combination with ethanol or THC (delta-9-tetrahydrocannabinol). [2011.02]
Methamphetamine dependence treatment rehabilitation in Thailand: a model assessment. [2011.01]
Minocycline attenuates subjective rewarding effects of dextroamphetamine in humans. [2011.01]
Dose effects and comparative effectiveness of extended release dexmethylphenidate
and mixed amphetamine salts. [2011]
Acute modafinil effects on attention and inhibitory control in
methamphetamine-dependent humans. [2011]
Urinary excretion kinetics of 3,4-methylenedioxymethamphetamine (MDMA, ecstasy)
and its phase I and phase II metabolites in humans following controlled MDMA
administration. [2011]
Poor response to sertraline in methamphetamine dependence is associated with
sustained craving for methamphetamine. [2011]
A randomized, placebo-controlled trial of sustained-release dextroamphetamine for
treatment of methamphetamine addiction. [2011]
Contingency management to reduce methamphetamine use and sexual risk among men who have sex with men: a randomized controlled trial. [2010.12.20]
Is ecstasy an "empathogen"? Effects of +/-3,4-methylenedioxymethamphetamine on prosocial feelings and identification of emotional states in others. [2010.12.15]
Investigating the mechanisms of hallucinogen-induced visions using 3,4-methylenedioxyamphetamine (MDA): a randomized controlled trial in humans. [2010.12.02]
Serum ferritin and amphetamine response in youth with attention-deficit/hyperactivity disorder. [2010.12]
The effects of modafinil treatment on neuropsychological and attentional bias performance during 7-day inpatient withdrawal from methamphetamine dependence. [2010.12]
Amphetamine-related improvement in executive function in patients with chronic schizophrenia is modulated by practice effects. [2010.12]
Sustained release d-amphetamine reduces cocaine but not 'speedball'-seeking in buprenorphine-maintained volunteers: a test of dual-agonist pharmacotherapy for cocaine/heroin polydrug abusers. [2010.12]
A double-blind, placebo-controlled study of N-acetyl cysteine plus naltrexone for methamphetamine dependence. [2010.11]
Anxiety disorders among methamphetamine dependent adults: association with post-treatment functioning. [2010.09]
Effect of D-amphetamine on inhibition and motor planning as a function of baseline performance. [2010.09]
The angiotensin-converting enzyme inhibitor perindopril treatment alters cardiovascular and subjective effects of methamphetamine in humans. [2010.08.30]
Estimating the intake of abused methamphetamines using experimenter-administered deuterium labeled R-methamphetamine: selection of the R-methamphetamine dose. [2010.08]
Modafinil administration improves working memory in methamphetamine-dependent individuals who demonstrate baseline impairment. [2010.07]
Predictors and consequences of incarceration among a sample of young Thai methamphetamine users. [2010.07]
Verbal memory improved by D-amphetamine: influence of the testing effect. [2010.07]
Stress-induced changes in mood and cortisol release predict mood effects of amphetamine. [2010.06.01]
Randomized, double-blind, placebo-controlled trial of modafinil for the treatment of methamphetamine dependence. [2010.06.01]
Use of an acute challenge with d-amphetamine to model cognitive improvement in chronic schizophrenia. [2010.06]
Feasibility and acceptability of a phase II randomized pharmacologic intervention for methamphetamine dependence in high-risk men who have sex with men. [2010.04.24]
Sustained release methylphenidate for the treatment of ADHD in amphetamine abusers: a pilot study. [2010.04.01]
Psychosocial treatment for methamphetamine use disorders: a preliminary randomized controlled trial of cognitive behavior therapy and Acceptance and Commitment Therapy. [2010.04]
It's the thought that counts: craving metacognitions and their role in abstinence from methamphetamine use. [2010.04]
Neurochemical alterations in methamphetamine-dependent patients treated with cytidine-5'-diphosphate choline: a longitudinal proton magnetic resonance spectroscopy study. [2010.04]
Cocaine choice in humans during D-amphetamine maintenance. [2010.04]
Polymorphisms in dopamine transporter (SLC6A3) are associated with stimulant effects of D-amphetamine: an exploratory pharmacogenetic study using healthy volunteers. [2010.03]
Pharmacokinetics of lisdexamfetamine dimesylate and its active metabolite, d-amphetamine, with increasing oral doses of lisdexamfetamine dimesylate in children with attention-deficit/hyperactivity disorder: a single-dose, randomized, open-label, crossover study. [2010.02]
Are attention lapses related to d-amphetamine liking? [2010.02]
More aroused, less fatigued: fatty acid amide hydrolase gene polymorphisms influence acute response to amphetamine. [2010.02]
Stereoselectivity in the human metabolism of methamphetamine. [2010.02]
Evaluation of modafinil effects on cardiovascular, subjective, and reinforcing effects of methamphetamine in methamphetamine-dependent volunteers. [2010.01.15]
Randomized controlled trial of dexamphetamine maintenance for the treatment of methamphetamine dependence. [2010.01]
Amphetamine-related improvement in executive function in patients with chronic
schizophrenia is modulated by practice effects. [2010]
Estimating the intake of abused methamphetamines using experimenter-administered
deuterium labeled R-methamphetamine: selection of the R-methamphetamine dose. [2010]
Use of an acute challenge with d-amphetamine to model cognitive improvement in
chronic schizophrenia. [2010]
Feasibility and acceptability of a phase II randomized pharmacologic intervention
for methamphetamine dependence in high-risk men who have sex with men. [2010]
Evaluation of modafinil effects on cardiovascular, subjective, and reinforcing
effects of methamphetamine in methamphetamine-dependent volunteers. [2010]
Evaluation of genetic variability in the dopamine receptor D2 in relation to behavioral inhibition and impulsivity/sensation seeking: an exploratory study with d-amphetamine in healthy participants. [2009.12]
Predicting adherence to treatment for methamphetamine dependence from neuropsychological and drug use variables. [2009.11.01]
The cardiovascular and subjective effects of methamphetamine combined with gamma-vinyl-gamma-aminobutyric acid (GVG) in non-treatment seeking methamphetamine-dependent volunteers. [2009.11]
Double-blind study of dextroamphetamine versus caffeine augmentation for treatment-resistant obsessive-compulsive disorder. [2009.11]
Further evidence of association between amphetamine response and SLC6A2 gene variants. [2009.10]
Effects of omeprazole on the pharmacokinetic profiles of lisdexamfetamine dimesylate and extended-release mixed amphetamine salts in adults. [2009.09]
Performance and subjective effects of diazepam and d-amphetamine in high and low sensation seekers. [2009.09]
Preventing growth in amphetamine use: long-term effects of the Midwestern Prevention Project (MPP) from early adolescence to early adulthood. [2009.08.04]
The effects of L-amphetamine sulfate on cognition in MS patients: results of a randomized controlled trial. [2009.07]
Correlates of incarceration among young methamphetamine users in Chiang Mai, Thailand. [2009.07]
Amphetamine-induced place preference in humans. [2009.05.15]
Effects of oral methamphetamine on cocaine use: a randomized, double-blind, placebo-controlled trial. [2009.04.01]
Depression among methamphetamine users: association with outcomes from the Methamphetamine Treatment Project at 3-year follow-up. [2009.04]
A randomized, double-blind, placebo-controlled trial assessing the impact of dexamphetamine on fatigue in patients with advanced cancer. [2009.04]
The effects of d-amphetamine on extrastriatal dopamine D2/D3 receptors: a randomized, double-blind, placebo-controlled PET study with [11C]FLB 457 in healthy subjects. [2009.03]
Sustaining executive functions during sleep deprivation: A comparison of caffeine, dextroamphetamine, and modafinil. [2009.02.01]
A double-blind, placebo-controlled trial of modafinil (200 mg/day) for methamphetamine dependence. [2009.02]
Cocaine effects during D-amphetamine maintenance: a human laboratory analysis of safety, tolerability and efficacy. [2009.01.01]
Evaluation of a peer network intervention trial among young methamphetamine users in Chiang Mai, Thailand. [2009.01]
Risk factors associated with methamphetamine use and heart failure among native Hawaiians and other Pacific Island peoples. [2009]
Atomoxetine attenuates dextroamphetamine effects in humans. [2009]
Effects of oral methamphetamine on cocaine use: A randomized, double-blind, placebo-controlled trial. [2008.12.04]
Evaluation of subjective effects of aripiprazole and methamphetamine in methamphetamine-dependent volunteers. [2008.12]
Methylphenidate and amphetamine do not induce cytogenetic damage in lymphocytes of children with ADHD. [2008.12]
Attention-deficit/hyperactivity disorder-specific quality of life with triple-bead mixed amphetamine salts (SPD465) in adults: Results of a randomized, double-blind, placebo-controlled study. [2008.11.04]
Naltrexone for the treatment of amphetamine dependence: a randomized, placebo-controlled trial. [2008.11]
Attention-deficit/hyperactivity disorder-specific quality of life with triple-bead mixed amphetamine salts (SPD465) in adults: results of a randomized, double-blind, placebo-controlled study. [2008.11]
Adolescent methamphetamine use and sexual risk behaviour in secondary school students in Cape Town, South Africa. [2008.11]
Restoration of risk-propensity during sleep deprivation: caffeine, dextroamphetamine, and modafinil. [2008.09]
Disulfiram enhances subjective effects of dextroamphetamine in humans. [2008.09]
Triple-bead mixed amphetamine salts (SPD465), a novel, enhanced extended-release amphetamine formulation for the treatment of adults with ADHD: a randomized, double-blind, multicenter, placebo-controlled study. [2008.09]
Effects of dextroamphetamine, caffeine and modafinil on psychomotor vigilance test performance after 44 h of continuous wakefulness. [2008.09]
Naltrexone attenuates the subjective effects of amphetamine in patients with amphetamine dependence. [2008.07]
Acute physiological and behavioral effects of intranasal methamphetamine in humans. [2008.07]
Effects of l-amphetamine sulfate on cognitive function in multiple sclerosis patients. [2008.06]
Methylphenidate for the treatment of apathy in Alzheimer disease: prediction of response using dextroamphetamine challenge. [2008.06]
A placebo-controlled trial of mirtazapine for the management of methamphetamine withdrawal. [2008.05]
The acetylcholinesterase inhibitor rivastigmine does not alter total choices for methamphetamine, but may reduce positive subjective effects, in a laboratory model of intravenous self-administration in human volunteers. [2008.04]
Bupropion for the treatment of methamphetamine dependence. [2008.04]
The explicit learning of new names for known objects is improved by dexamphetamine. [2008.03]
|